82
Views
6
CrossRef citations to date
0
Altmetric
Original Research

Prognostic Factors for Patients with Esophageal Cancer Receiving Definitive Radiotherapy Alone: A Retrospective Analysis

, , , , , ORCID Icon & show all
Pages 3229-3234 | Published online: 13 Apr 2021

References

  • Chen WK, Sun R, Zheng H, et al. Cancer incidence and mortality in China, 2014. Chinese J Cancer Res. 2018;30(1):1–12. doi:10.21147/j.issn.1000-9604.2018.01.01
  • Chen WQ, Li H, Sun KX, et al. Report of cancer incidence and mortality in China, 2014. Zhonghua Zhong Liu Za Zhi. 2018;40(1):5–13. doi:10.3760/cma.j.issn.0253-3766.2018.01.00229365411
  • Allum WH, Stenning SP, Bancewicz J, et al. Long-term results of a randomized trial of surgery with or without preoperative chemotherapy in esophageal cancer. J Clin Oncol. 2009;27:5062–5067. doi:10.1200/JCO.2009.22.208319770374
  • Sjoquist KM, Burmeister BH, Smithers BM, et al. Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal carcinoma: an updated meta-analysis. Lancet Oncol. 2011;12:681–692. doi:10.1016/S1470-2045(11)70142-521684205
  • Koppert LB, Lemmens VE, Coebergh JW, et al. Impact of age and comorbidity on surgical resection rate and survival in patients with oesophageal and gastric cancer. Br J Surg. 2012;99:1693–1700. doi:10.1002/bjs.895223132417
  • Loffeld RJ, Dekkers PE. Experience with oesophageal cancer: a ten-year single centre study reflecting daily practice. ISRN Gastroenterol. 2013;2013:205417. doi:10.1155/2013/20541723710364
  • Hongo M, Nagasaki Y, Shoji T. Epidemiology of esophageal cancer: orient to occident. Effects of chronology, geography and ethnicity. J Gastroenterol Hepatol. 2009;24:729–735. doi:10.1111/j.1440-1746.2009.05824.x19646015
  • Eslick GD. Epidemiology of esophageal cancer. Gastroenterol Clin North Am. 2009;38:17–25 vii. doi:10.1016/j.gtc.2009.01.00819327565
  • Gao QY, Fang JY. Early esophageal cancer screening in China. Best Pract Res Clin Gastroenterol. 2015;29:885–893. doi:10.1016/j.bpg.2015.09.01826651250
  • Trivers KF, Sabatino SA, Stewart SL. Trends in esophageal cancer incidence by histology, United States, 1998–2003. Int J Cancer. 2008;123:1422–1428. doi:10.1002/ijc.2369118546259
  • Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018. CA Cancer J Clin. 2018;68:7–30. doi:10.3322/caac.2144229313949
  • Siegel RL, Miller KD, Jemal A. Cancer statistics, 2017. CA Cancer J Clin. 2017;67:7–30. doi:10.3322/caac.2138728055103
  • Vellayappan BA, Soon YY, Ku GY, et al. Chemoradiotherapy versus chemoradiotherapy plus surgery for esophageal cancer. Cochrane Database Syst Rev. 2017;8:CD010511.28829911
  • Liu B, Bo Y, Wang K, et al. Concurrent neoadjuvant chemoradiotherapy could improve survival outcomes for patients with esophageal cancer: a meta-analysis based on random clinical trials. Oncotarget. 2017;8:20410–20417. doi:10.18632/oncotarget.1466928099899
  • Sasaki Y, Kato K. Chemoradiotherapy for esophageal squamous cell cancer. Jpn J Clin Oncol. 2016;46:805–810. doi:10.1093/jjco/hyw08227380810
  • Mizowaki T. Intensity-modulated radiation therapy (IMRT). Nihon Rinsho. 2011;69(Suppl 5):412–417.
  • Fokas E, Weiss C, Rödel C. The role of radiotherapy in the multimodal management of esophageal cancer. Dig Dis. 2013;31:30–37. doi:10.1159/00034717023797120
  • Serkies K, Badzio A, Jassem J. The role of radiotherapy in the management of esophageal cancer. Pol Merkur Lekarski. 2005;18:332–335.15997646
  • Wolf M, Zehentmayr F, Niyazi M, et al. Long-term outcome of mitomycin C- and 5-FU-based primary radiochemotherapy for esophageal cancer. Strahlenther Onkol. 2010;186:374–381. doi:10.1007/s00066-010-2137-y20582393
  • Geh JI, Bond SJ, Bentzen SM, et al. Systematic overview of preoperative (neoadjuvant) chemoradiotherapy trials in oesophageal cancer: evidence of a radiation and chemotherapy dose response. Radiother Oncol. 2006;78:236–244. doi:10.1016/j.radonc.2006.01.00916545878
  • Verma V, Moreno AC, Lin SH. Advances in radiotherapy management of esophageal cancer. J Clin Med. 2016;5:E91. doi:10.3390/jcm510009127775643
  • Ariga H, Nemoto K, Miyazaki S, et al. Prospective comparison of surgery alone and chemoradiotherapy with selective surgery in resectable squamous cell carcinoma of the esophagus. Int J Radiat Oncol Biol Phys. 2009;75:348–356. doi:10.1016/j.ijrobp.2009.02.08619735862
  • Teoh AY, Chiu PW, Yeung WK, et al. Long-term survival outcomes after definitive chemoradiation versus surgery in patients with resectable squamous carcinoma of the esophagus: results from a randomized controlled trial. Ann Oncol. 2013;24:165–171. doi:10.1093/annonc/mds20622887465
  • Yin H, Li D, Zhu C, et al. Factors relevant to the prognosis of patients with esophageal cancer who received intensity-modulated radiotherapy. Thoracic Cancer. 2018;9:1215–1219. doi:10.1111/1759-7714.1280030070063
  • Cheng Y, Chen H, Wu S, et al. Esophageal squamous cell carcinoma and prognosis in Taiwan. Cancer Med. 2018;7(9):4193–4201. doi:10.1002/cam4.149930047253